Diabetes Management: VNA Ohio's Evidence-Based Home Education Program Diabetes affects adults, with poor management creating annual healthcare costs. VNA Ohio's comprehensive diabetes program demonstrates significant clinical and financial outcomes. Program Components: Certified diabetes educators providing skilled nursing at home Personalized education on glucose monitoring and medication management Nutritional counseling and meal planning coordination Diabetic foot care and complication prevention Home health care Ohio integration with endocrinology practices Medicare Coverage: Diabetes self-management education and medical nutrition therapy covered under Medicare Part B, creating accessible care for Greater Cleveland healthcare populations. ROI Analysis: Every dollar invested in diabetes education returns $3.20 through prevented complications and reduced acute care utilization. 125+ years of clinical excellence in chronic disease management. #DiabetesManagement #ChronicCareManagement #PatientEducation #Medicare #ValueBasedCare #VNAOhio

Every referring doctor knows the moment. A patient in front of you with newly diagnosed type 2 diabetes. Or stage 3 CKD. Or IBS-D that's ruined three holidays. Or a PCOS diagnosis they're still processing. Nutrition is written into their treatment plan — because the evidence is clear that it changes outcomes. But where do you send them? And how do you know they'll be in competent, evidence-based hands — not someone pushing shakes or a 1200-kcal meal plan? That's why Reset Health Dietitians exists. We're a Cape Town Northern Suburbs practice built around three principles: → Evidence-based MNT, grounded in ESPEN, ADA, SEMDSA, NICE, KDOQI, and BDA guidance → Weight-inclusive, non-diet-culture care → Tight MDT collaboration — we'll call your rooms if we need to, and we write motivation letters without being asked We cover oncology, diabetes, PCOS, IBS and gut health, renal (pre-dialysis and dialysis), cardiovascular, bariatric, eating disorders, dysphagia, and inpatient care at Louis Leipoldt Mediclinic (Bellville/Panorama practice) and Durbanville Mediclinic (Durbanville practice). We also offer InBody bioelectrical impedance for body composition assessment — a genuinely useful data point when BMI is hiding the full picture. If you have a patient who needs dietetic input, we're here. ── REFER A PATIENT ── 📍 Bellville + Panorama (incl. Louis Leipoldt Mediclinic inpatient): 064 502 8158 · info@resethealth.co.za 📍 Durbanville (incl. Durbanville Mediclinic inpatient): 084 745 9536 · saskia@resethealth.co.za Website: resethealth.co.za #ClinicalNutrition #Dietitian #CapeTownMedical #MedicalNutritionTherapy #MDT

Saturday morning thought while tidying up at home: when was the last time you reviewed your medication list? Many adults accumulate prescriptions and over-the-counter medications over time, particularly when managing chronic conditions. While long-term medication therapy is often appropriate—and sometimes essential—it’s also worth recognizing that healthcare needs evolve. Periodic medication review (sometimes called medication reconciliation or deprescribing review when appropriate) can help identify opportunities to improve safety, reduce unnecessary treatment burden, and ensure therapy still aligns with current health goals. A few practical weekend reminders: ✔️ Check expiration dates on prescription and OTC medications ✔️ Safely dispose of expired or unused medications ✔️ Keep an updated medication list ✔️ Bring long-term medications up at your next primary care visit Why does this matter? Research consistently shows that polypharmacy (commonly defined as taking multiple medications, often 5+) is associated with increased risks of adverse drug events, medication interactions, falls in older adults, and treatment burden. At the same time, appropriate long-term therapy for conditions such as hypertension, diabetes, cardiovascular disease, asthma, or thyroid disorders can significantly reduce complications and improve outcomes. The question is not whether long-term medications are “good” or “bad.” The better question is: Does this medication still make sense for this patient, at this point in time? Medication reviews can uncover: • Therapies that remain essential • Medications causing overlooked side effects • Duplicate or no-longer-indicated treatments • Opportunities to simplify regimens and improve adherence Important note: medications should never be stopped abruptly without clinician guidance. As clinicians or patients, have you ever had a medication review that meaningfully simplified care? #PrimaryCare #MedicationSafety #Deprescribing #ChronicDiseaseManagement #PatientSafety #HealthcareLeadership #PreventiveCare #FamilyMedicine

Saveetha college of Pharmacy, Saveetha Institute of Medical and Technical Sciences organized a program on Sustainable Development Goals (SDGs) focusing on diabetes care. The session titled “Integrated SDG-Based Approach for Diabetes Prevention and Management” was delivered by Dr. E. Bhavya, Professor and Head, Department of Pharmacy Practice. The program was held on 02 May 2026 at 9:00 AM in A1, AHS Block. The session focused on: Awareness about Diabetes Mellitus Importance of healthy diet and lifestyle (SDG 2 & SDG 3) Role of education in prevention (SDG 4) Need to reduce health inequalities (SDG 10) The speaker explained how early screening, proper medication use, and lifestyle changes can help in preventing and managing diabetes. Overall, the program was informative and helped participants understand the importance of SDGs in improving diabetes care.

“𝗦𝘁𝗶𝗹𝗹” 𝗶𝘀 𝗮 𝗱𝗶𝗳𝗳𝗶𝗰𝘂𝗹𝘁 𝘄𝗼𝗿𝗱 𝘁𝗼 𝗿𝗲𝗮𝗱 𝗶𝗻 𝗮𝘀𝘁𝗵𝗺𝗮 𝗰𝗮𝗿𝗲. 𝗪𝗼𝗿𝗹𝗱 𝗔𝘀𝘁𝗵𝗺𝗮 𝗗𝗮𝘆 𝟮𝟬𝟮𝟲: “𝘈𝘤𝘤𝘦𝘴𝘴 𝘵𝘰 𝘢𝘯𝘵𝘪-𝘪𝘯𝘧𝘭𝘢𝘮𝘮𝘢𝘵𝘰𝘳𝘺 𝘪𝘯𝘩𝘢𝘭𝘦𝘳𝘴 𝘧𝘰𝘳 𝘦𝘷𝘦𝘳𝘺𝘰𝘯𝘦 - 𝘴𝘵𝘪𝘭𝘭 𝘢𝘯 𝘶𝘳𝘨𝘦𝘯𝘵 𝘯𝘦𝘦𝘥”. “𝗦𝘁𝗶𝗹𝗹” shouldn’t be here. We already know 𝘢𝘯𝘵𝘪‐𝘪𝘯𝘧𝘭𝘢𝘮𝘮𝘢𝘵𝘰𝘳𝘺 𝘪𝘯𝘩𝘢𝘭𝘦𝘳𝘴 𝘳𝘦𝘥𝘶𝘤𝘦 𝘦𝘹𝘢𝘤𝘦𝘳𝘣𝘢𝘵𝘪𝘰𝘯𝘴, 𝘩𝘰𝘴𝘱𝘪𝘵𝘢𝘭𝘪𝘻𝘢𝘵𝘪𝘰𝘯𝘴, 𝘢𝘯𝘥 𝘱𝘳𝘦𝘷𝘦𝘯𝘵𝘢𝘣𝘭𝘦 𝘥𝘦𝘢𝘵𝘩𝘴. Yet asthma still claims over 450,000 lives each year , most of them avoidable. [GINA, 2026] Two decades into practice, I’ve lost count of how often I’ve seen the same asthma story again and again… across countries, across time zones. Patients who have relied only on blue reliever inhalers for years. Or patients prescribed preventers, but never truly explained 𝘸𝘩𝘺 they matter or how essential they are. Relievers treat symptoms. They 𝗱𝗼 𝗻𝗼𝘁 treat the disease. In real clinical settings, this variation in prescription shows up as inconsistency in how care is delivered from one encounter to another. Seen through a Lean Six Sigma lens, the question becomes harder to ignore: Where in the chain is the defect being introduced? • At prescribing? • In patient education that isn’t standardized? • In missing follow-up and reinforcement? • Or in the inconsistency between clinicians and the system they work in? Across the different cities I’ve worked in, I’ve made a conscious effort to keep variability in practice as low as possible. But I also recognise that this isn’t uniformly the case across clinicians or settings. So the question may not be whether an individual doctor is up to date. It may be more important to ask whether the system is designed to reliably make the right practice happen consistently, every time. Thats why this year’s theme is as much about healthcare delivery design as it is about pharmacology. So I’ll leave with a more uncomfortable question: In your setting, what needs to be revisited : access, affordability, or awareness? I’m listening. #DrPadmavathyRamadoss Pulmonologist | Medical Division Head Founder, #Padmanology™ & #TheHealthyLung™ #WorldAsthmaDay2026 #Asthma #HealthEquity #HealthcareLeadership #LeanSixSigma #QualityInHealthcare

Registrations are now open for our Palliative Medicine course on 23 June. Using case-based presentations, evidence based discussions, sessions will provide practical, clinically relevant learning to support confident, compassionate care. Get the latest updates on the assessment and management of complex symptoms and challenging clinical decision-making in patients with advanced illness. During the course we will explore: ✅ Managing uncontrolled cancer-related pain in the AMU ✅ Recognition and management of palliative care emergencies ✅ Supporting patients who are distressed ✅The role of clinically assisted nutrition and hydration ✅Reframing a good death ✅Breathlessness in patients with known lung-cancer ✅Symptoms and management of raised intracranial pressure Using case-based presentations, evidence based discussions and the insights and experience of colleagues, each session will provide practical, clinically relevant learning to support confident, compassionate care. More info and full programme here: https://lnkd.in/eBVgk6ym

Why ApoB should be on every lipid panel. As a nurse practitioner working in the cardiometabolic space, I’m seeing a pattern we can’t ignore: Patients with: ✔️ Normal LDL-C ✔️ Normal total cholesterol ✔️ Good HDL ✔️ Normal triglycerides …but elevated ApoB. At first glance, these labs look “normal.” They’re not. -LDL-C measures cholesterol content. - ApoB measures the number of atherogenic particles. And in atherosclerosis: particle number — not cholesterol mass — drives risk. This ApoB–LDL discordance often reflects: • Increased small, dense LDL particles • Early insulin resistance • Higher atherogenic burden despite “normal” labs Clinical reality: If ApoB is elevated — even with normal LDL-C: ➡️ This is not low risk ➡️ This is missed cardiovascular risk ➡️ This patient should be approached as metabolic + atherogenic risk 👉 And importantly: If ApoB is elevated, consider checking hs-CRP to assess underlying inflammation — another key driver of atherosclerosis. Bottom line 👉 We are missing risk by relying on basic lipid panels alone. 👉 ApoB should be part of routine cholesterol testing. Because prevention starts with measuring what actually drives disease. Are you checking ApoB routinely in your patients? #ApoB #CardiometabolicHealth #PreventiveCardiology #Lipidology #HeartHealth #NursePractitioner #FunctionalMedicine #InsulinResistance #Cholesterol #PrimaryCare #PreventiveMedicine #ASCVD #Inflammation #hsCRP

https://zurl.co/f1r5c Obese patients in intensive care may show better ICU and hospital survival despite reduced long-term life expectancy. Treatment, survival, selection and reverse causation biases complicate interpretation, while BMI can miss central adiposity and hidden sarcopenia. Important gaps remain in drug dosing, nutrition requirements and prediction tools for obese critically ill patients.

Post-stroke dysphagia is a driver of longer hospital and ICU stays and is associated with aspiration pneumonia, poor nutrition, and feeding tube dependence. Clinical evidence shows use of the Phagenyx® System results in: ▪️ 5 fewer days in the ICU ▪️ 6 days faster return to oral nutrition ▪️ 8 fewer days in the hospital Phagenyx® promotes neurological recovery and improves swallow safety and efficiency for patients with severe dysphagia post-stroke.

A 53yo woman. A BMI of 15.6. A GJ tube. And a readmission just 3 weeks after discharge. This “Teachable Moment,” published in JAMA Internal Medicine this month, is frustrating to read. Not because it's rare, but because it's not. Patients go home with feeding tubes every single day and in many hospitals they leave without ever having a meaningful conversation with a dietitian about how to manage them. As an RDN, I think about what a difference early and sustained nutrition intervention makes in these cases: 👉A dietitian embedded in the discharge planning process (not consulted at 4pm on a Friday) with time to assess tolerance risk, tailor the feeding regimen, and coordinate follow-up 👉Clinicians with real competency in enteral nutrition: understanding GJ vs gastrostomy physiology, troubleshooting intolerance, recognizing when something is wrong before it becomes a readmission 👉An outpatient system that doesn't abandon patients the moment they walk out the door but rather a scheduled RDN follow-up, not just a hotline number The evidence for nutrition support teams and RD-led home enteral nutrition clinics is there. What's missing is the staffing, the infrastructure, and frankly, the institutional will to prioritize it. This case is not only a Teachable Moment for clinicians, but should also be a policy awareness moment for health systems. ❓How are your institutions handling feeding tube discharge planning? I'd love to hear what's working! 📄 Oschmann AW et al. Gastrojejunostomy Tube Intolerance. JAMA Intern Med. April 2026. doi:10.1001/jamainternmed.2026.0279